PBS-MHE-2019: Efficiency of an mHealth Intervention on the Health Literacy Improvement and Self-management.

Sponsor
Instituto de investigación e innovación biomédica de Cádiz (Other)
Overall Status
Recruiting
CT.gov ID
NCT04725526
Collaborator
(none)
236
2
2
46
118
2.6

Study Details

Study Description

Brief Summary

Multipathological patients with complex health needs are responsible for the majority number of avoidable hospital admissions.

The expansion of mHealth interventions in the field of communication with the patient, the reduction of health inequalities, the improvement in access to health resources, the adherence to treatments and self-care of chronic diseases lead to an optimistic horizon . However, there are few applications that demonstrate its effectiveness in these patients, which is diminished when they are not based on evidence, nor are designed by and for users with different levels of health literacy.

Condition or Disease Intervention/Treatment Phase
  • Device: Mobile phone compatible with iOS or Android
N/A

Detailed Description

Objective: to evaluate the efficacy of an mHealth intervention, with respect to routine clinical practice, to improve health literacy and self-management of the multiple pathological patient with heart failure and complex health needs.

Hypothesis: the proposed mHealth intervention is more effective than usual clinical practice, favoring health literacy and self-management of multiple pathological patients with heart failure and complex health needs, so its use would be relevant as part of the assistance process.

Methodology: randomized, controlled, multicenter clinical trial for the evaluation of the efficacy of an mHealth intervention with two groups: a control group (routine clinical practice) and an experimental group (routine clinical practice together with ad hoc designed mHealth intervention).

In this project, the design and content validation of the mHealth tool will be carried out, evaluating its relevance and suitability.

Study Design

Study Type:
Interventional
Anticipated Enrollment :
236 participants
Allocation:
Randomized
Intervention Model:
Parallel Assignment
Masking:
None (Open Label)
Primary Purpose:
Other
Official Title:
Development and Efficiency of an mHealth Intervention on the Health Literacy Improvement and Self-management of the Multi-pathological Patient With Heart Failure: a Randomized Controlled Trial.
Actual Study Start Date :
Mar 1, 2020
Anticipated Primary Completion Date :
Jan 1, 2023
Anticipated Study Completion Date :
Jan 1, 2024

Arms and Interventions

Arm Intervention/Treatment
No Intervention: usual clinical practice

A group of pluripatological patients with heart failure and complex needs of health will be tratad per standard of care on site

Experimental: mHealth intervention plus usual clinical practice

A group of pluripatological patients with heart failure and complex needs of health will be tratad per standard of care plus mHealth intervention on site

Device: Mobile phone compatible with iOS or Android
MHealth (mobile health) intervention is an act whose purpose is to improve, maintain, promote or modify health, functioning or health conditions.

Outcome Measures

Primary Outcome Measures

  1. Health literacy [1 year]

    Literacy on health defined by points (range 0-50)

  2. General selfmanagement [1 year]

    Selfmanagement on health (scale 1-5)

  3. selfmanagement on heart failure [1 year]

    European Heart Failure SelfCare Behavior Scale (range 12-60)

Secondary Outcome Measures

  1. self-independence [1 year]

    Personal grade of self-independence- Barthel Index

  2. self-independence 2 [1 year]

    Personal grade of self-independence- Lawton and Brody Index

  3. Adherence to treatments [1 year]

    Adherence to treatments measured by Morisky-Green Questionnaire

  4. Prognosis [1 year]

    Life prognosis using PROFUND Index

  5. Patient satisfaction [1 year]

    General patient satisfaction using a simple questionnarie

  6. Patient satisfaction 2 [1 year]

    Patients satisfaction related to mHealth device

Eligibility Criteria

Criteria

Ages Eligible for Study:
18 Years and Older
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
No
Inclusion Criteria:
  • Patients of both sexes and over 18 years of age;

  • Attended by the health professionals of the Basic Health Areas that are participating in the study;

  • Patients that give their consent to participate in the study by signing an informed consent;

  • Patients that have a mobile device (Smartphone or Tablet) compatible with the Android or iOS operating system;

  • Patients considered as multi-pathological based on the following criteria from those described in the Integrated Healthcare Process (Ollero et al., 2018):

  • Be classified in clinical category A of chronic pathologies due to heart failure that, in a situation of clinical stability, has been in NYHA grade II, being able to be simultaneously classified, or not, in other clinical categories due to suffering from another disease Chronicles.

  • Patients with at least one of the following complexity criteria: Extreme polypharmacy (10 or more active ingredients for chronic prescription); Socio-family risk (score on the Gijon scale greater than 10 points); Stage II or higher pressure ulcers; Malnutrition (BMI <18.5); Feeding with chronic and prescription tube (3 or more months); Two or more hospital admissions in the previous 12 months.

Exclusion Criteria:
  • Patients with sensory deficits and/or mobility problems in the upper limbs that prevent them from using the application correctly, despite using the accessibility features of mobile devices;

  • Patients with persistent cognitive impairment (Pfeiffer test with 5 or more errors or Lobo's mini-cognitive exam <23 points) and / or severe mental disorder;

  • Patients with serious limitations for AVBD (Barthel index <20 points).

Contacts and Locations

Locations

Site City State Country Postal Code
1 Health Management area of Gibraltar Algeciras Cádiz Spain 11207
2 F. para la Gestión de la Inv. Biomédica de Cádiz Ríos Cadiz Spain 11009

Sponsors and Collaborators

  • Instituto de investigación e innovación biomédica de Cádiz

Investigators

  • Principal Investigator: Pilar Bas Sarmiento, MD, Instituto de investigación e innovación biomédica de Cádiz
  • Principal Investigator: Martina Fernández Gutiérrez, Instituto de investigación e innovación biomédica de Cádiz

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
Instituto de investigación e innovación biomédica de Cádiz
ClinicalTrials.gov Identifier:
NCT04725526
Other Study ID Numbers:
  • PBS-MHE-2019
First Posted:
Jan 26, 2021
Last Update Posted:
Aug 8, 2022
Last Verified:
Dec 1, 2021
Individual Participant Data (IPD) Sharing Statement:
No
Plan to Share IPD:
No
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Keywords provided by Instituto de investigación e innovación biomédica de Cádiz
Additional relevant MeSH terms:

Study Results

No Results Posted as of Aug 8, 2022